Multi-drug resistant Acinetobacter ventilator-associated pneumonia

Lung India

Volumn 27, Issue 4, 2010, Pages 217-220

  Shete, Vishal B ^a   Ghadage, Dnyaneshwari P ^b   Muley, Vrishali A ^b   Bhore, Arvind V ^b  

^a B J MEDICAL COLLEGE   (India)

^b GENERAL HOSPITAL   (India)

Author keywords

Acinetobacter; multi drug resistance; ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; TETRACYCLINE;

ACINETOBACTER; ACINETOBACTER INFECTION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BRAIN HEMORRHAGE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DRUG RESISTANCE; DRUG SURVEILLANCE PROGRAM; HEAD INJURY; HUMAN; HUMAN TISSUE; INFECTION CONTROL; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; NONHUMAN; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 78149378193     PISSN: 09702113     EISSN: 0974598X     Source Type: Journal    
DOI: 10.4103/0970-2113.71952     Document Type: Article

References (22)

1. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA. Boucher comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clinical Infectious Diseases 2002;34:1425-30.
2. Garnacho-Montero J, Ortiz-Leyba C, Jiménez-Jiménez FJ, Barrero- Almodóvar AE, García-Garmendia JL, Bernabeu-WittelI M, et al, Treatment of multidrug-resistant Acinetobacter baumannii Ventilator- Associated Pneumonia (VAP) with Intravenous Colistin: A comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-8.
3. Baraibar J, Correa H, Mariscal D, Gallego M, Valles J, Rello J. Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia. Chest 1997;112:1050-4.
4. Joly-Guillou ML, Wolff M, Pocidalo JJ, Walker F, Carbon C. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agents Chemother 1997;41:345-51.
5. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al, Nosocomial acquisition of multiresistant Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis 1995;20:790-6.
6. Pugin J. Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol 2002;68:261-5.
7. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr. Color atlas and textbook of diagnostic microbiology. 5th ed. Lippincott Williams and Wilkins; 2006.
8. Bergmans DC, Borten MJ, De Lecuw PW, Stobberingh EE. Reproducibility of quantitative cultures of endotracheal aspirates from mechanically ventilated patients. J Clin Microbiol 1997;35:796-8.
9. Ibrahim A, Gerner-Smidt P, Liesack W. Phylogenetic relationship of the twenty one DNA groups of the genus Acinetobacter as revealed by 16 S ribosomal DNA sequence analysis. Int J Syst Bacteriol 1997;47:837-41.
10. Nemec A, Dijkshoorn L, Cleenwerck I, de Baere T, Janssens D, van der Reijden TJ, et al, Acinetobacter parvus sp. Nov. A small colony forming species isolated from human clinical specimens. Int J Syst Evol Microbiol 2003;53:1563-7.
11. Clinical Laboratory and Standards Institutes 2004: Performance Standards For Antimicrobial Susceptibility Testing; Fourteenth informational supplement M100-S14 Vol.24 No.1 Pennsylvania USA 2004.
12. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al, Ventilator-associated pneumonia caused by potentially drugresistant bacteria. Am J Respir Crit Care Med 1998;157:531-9.
13. Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000;31:101-6.
14. Paterson DL. The epidemiological profile of infections with multi-drug resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006;43:S43-8.
15. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al, Risk factors for an outbreak of multi-drug-resistant acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82.
16. Garnacho-Montero J, Ortiz - Leyba C, Fernandez-Hinojosa E, Aldaboallas T, Cayuela A, Marquez-Vacaro JA, et al, Acinetobacter baumannii ventilator-associated pneumonia: Epidemiological and clinical findings. Intensive Care Med 2005;31:649-55.
17. Gales AC, Jones RN, Forward KR, Liñares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001;32:S104-13.
18. Gladstone P, Rajendran P, Brahmadathan KN. Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian J Med Microbiol 2005;23:189-91.
19. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, et al, Nosocomial Acinetobacter baumannii infections: Microbiological and clinical epidemiology. Ann Intern Med 1998;129:182-9.
20. Scerpella EG, Wanger AR, Armitige L, Anderlini P, Ericsson CD. Nosocomial outbreak caused by a multiresistant clone of Acinetobacter baumannii: Results of the case-control and molecular epidemiologic investigations. Infect Control Hosp Epidemiol 1995;16:92-7.
21. Carbonne A, Naas T, Blanckert K, Couzigou C, Cattoen C, Chagnon JL, et al, Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect 2005;60:14-8.
22. Bonomo RA, Szabo D. Mechanisms of multi-drug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006;43:S49-56.